Safety Monitoring: Who Needs Enhanced Lab Surveillance Patients with pre-existing kidney disease, liver cirrhosis, thyroid nodules, or personal/family history of medullary thyroid cancer require more frequent biomarker checks and may not be candidates for GLP-1 therapy
In the ACHIEVE-3 head-to-head against oral semaglutide in T2D, 36 mg orforglipron produced about 9.2% body weight reduction versus about 5.3% on 14 mg oral semaglutide, and superior HbA1c reduction
Collectively, neurodegenerative disorders and aging are associated with mitochondrial dysfunction, wherein two critical MQC pathwaysmitochondrial fission/fusion dynamics and mitophagyare significantly compromised (Nibrad et al
Yes, Tesamorelin and Ipamorelin can cause side effects such as skin irritation, headaches, fatigue, hormonal imbalances, mood fluctuations, and fluid retention
Seah BC-Q, Teo BM